Australia · Delayed Price · Currency is AUD BLS Pharmaceuticals Statistics
Total Valuation
ASX:BLS has a market cap or net worth of AUD 211.58 million. The enterprise value is 209.34 million.
| Market Cap | 211.58M |
| Enterprise Value | 209.34M |
Important Dates
The next confirmed earnings date is Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:BLS has 229.98 million shares outstanding. The number of shares has increased by 11.95% in one year.
| Current Share Class | 229.98M |
| Shares Outstanding | 229.98M |
| Shares Change (YoY) | +11.95% |
| Shares Change (QoQ) | +4.16% |
| Owned by Insiders (%) | 51.58% |
| Owned by Institutions (%) | n/a |
| Float | 75.02M |
Valuation Ratios
The trailing PE ratio is 23.18.
| PE Ratio | 23.18 |
| Forward PE | n/a |
| PS Ratio | 4.41 |
| PB Ratio | 10.49 |
| P/TBV Ratio | 10.67 |
| P/FCF Ratio | 746.74 |
| P/OCF Ratio | 104.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.69, with an EV/FCF ratio of 738.85.
| EV / Earnings | 23.35 |
| EV / Sales | 4.37 |
| EV / EBITDA | 19.69 |
| EV / EBIT | 21.13 |
| EV / FCF | 738.85 |
Financial Position
The company has a current ratio of 2.79, with a Debt / Equity ratio of 0.27.
| Current Ratio | 2.79 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 0.50 |
| Debt / FCF | 18.94 |
| Interest Coverage | 237.82 |
Financial Efficiency
Return on equity (ROE) is 66.14% and return on invested capital (ROIC) is 36.27%.
| Return on Equity (ROE) | 66.14% |
| Return on Assets (ROA) | 24.99% |
| Return on Invested Capital (ROIC) | 36.27% |
| Return on Capital Employed (ROCE) | 40.72% |
| Weighted Average Cost of Capital (WACC) | 7.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.94 |
| Inventory Turnover | 3.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +76.47% in the last 52 weeks. The beta is 0.62, so ASX:BLS's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +76.47% |
| 50-Day Moving Average | 0.89 |
| 200-Day Moving Average | 0.60 |
| Relative Strength Index (RSI) | 55.00 |
| Average Volume (20 Days) | 145,153 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:BLS had revenue of AUD 47.95 million and earned 8.97 million in profits. Earnings per share was 0.04.
| Revenue | 47.95M |
| Gross Profit | 19.69M |
| Operating Income | 9.91M |
| Pretax Income | 8.94M |
| Net Income | 8.97M |
| EBITDA | 10.20M |
| EBIT | 9.91M |
| Earnings Per Share (EPS) | 0.04 |
Balance Sheet
The company has 7.60 million in cash and 5.37 million in debt, with a net cash position of 2.24 million or 0.01 per share.
| Cash & Cash Equivalents | 7.60M |
| Total Debt | 5.37M |
| Net Cash | 2.24M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 20.17M |
| Book Value Per Share | 0.09 |
| Working Capital | 18.39M |
Cash Flow
In the last 12 months, operating cash flow was 2.02 million and capital expenditures -1.74 million, giving a free cash flow of 283,338.
| Operating Cash Flow | 2.02M |
| Capital Expenditures | -1.74M |
| Depreciation & Amortization | 290,195 |
| Net Borrowing | 2.10M |
| Free Cash Flow | 283,338 |
| FCF Per Share | 0.00 |
Margins
Gross margin is 41.05%, with operating and profit margins of 20.66% and 18.70%.
| Gross Margin | 41.05% |
| Operating Margin | 20.66% |
| Pretax Margin | 18.65% |
| Profit Margin | 18.70% |
| EBITDA Margin | 21.26% |
| EBIT Margin | 20.66% |
| FCF Margin | 0.59% |
Dividends & Yields
ASX:BLS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.95% |
| Shareholder Yield | -11.95% |
| Earnings Yield | 4.24% |
| FCF Yield | 0.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 24, 2026. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jun 24, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
ASX:BLS has an Altman Z-Score of 6.04 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.04 |
| Piotroski F-Score | 5 |